Company intelligence / Profile preview

Kalos Medical

Ownership: Private
Development stage: Commercial

Overview

Kalos Medical has developed DENEX™, a minimally invasive catheter-based medical device for the treatment of hypertension via renal denervation. The system uses radiofrequency energy delivered through electrodes to deactivate renal sympathetic nerves, reducing blood pressure. DENEX™ has received South Korea’s MFDS Innovative Medical Device designation and is currently undergoing clinical trials in Korea and Europe.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Drug pipeline

2 assets

DENEX

Clinical Trial

Indications: Treatment-resistant hypertension

1 more asset in the full pipeline.

Request access →

Partnerships

MNTekKorea Electronics Technology Institute (KETI)Seoul National University Bundang Hospital

Beyond the preview

Go deeper on Kalos Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kalos Medical.

Explore the full profile